Immunic
(NASDAQ) IMUX
Immunic Financials at a Glance
Market Cap
$143.51M
Revenue (TTM)
$0.00
Net Income (TTM)
$97.17M
EPS (TTM)
$-0.75
P/E Ratio
-1.47
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$1.08
Volume
2,024,336
Open
$1.15
Price
$1.08
Volume
2,024,336
Open
$1.15
Previous Close
$1.10
Daily Range
$1.07 - $1.16
52-Week Range
$0.51 - $1.51
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$1.08
Volume
2,024,336
Open
$1.15
Previous Close
$1.10
Daily Range
$1.07 - $1.16
52-Week Range
$0.51 - $1.51
IMUX News
IMUX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immunic
Industry
Biotechnology
Sector
Health CareEmployees
92
CEO
Daniel Vitt, PhD
Website
imux.comHeadquarters
New York City, NY 10036, US
IMUX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-1653%
Return on Capital
16%
Return on Assets
-4%
Earnings Yield
-68.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$143.51M
Shares Outstanding
130.47M
Volume
2.02M
Short Interest
0.00%
Avg. Volume
3.45M
Financials (TTM)
Gross Profit
$168.00K
Operating Income
$103.23M
EBITDA
$97.00M
Operating Cash Flow
$85.81M
Capital Expenditure
$161.00K
Free Cash Flow
$85.97M
Cash & ST Invst.
$15.48M
Total Debt
$684.00K
Immunic Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$42.00K
-20.0%
Gross Margin
0.00%
N/A
Market Cap
$143.51M
N/A
Market Cap/Employee
$1.58M
N/A
Employees
91
N/A
Net Income
$19.30M
+23.3%
EBITDA
$19.26M
+23.4%
Quarterly Fundamentals
Net Cash
$14.80M
-57.3%
Accounts Receivable
$4.12M
+502.6%
Inventory
$0.00
N/A
Long Term Debt
$214.00K
-18.9%
Short Term Debt
$470.00K
-36.5%
Return on Assets
-4.04%
N/A
Return on Invested Capital
15.72%
N/A
Free Cash Flow
$19.29M
+16.0%
Operating Cash Flow
$19.28M
+16.0%